Session Type
Meeting
Search Results for Cancer screening
Oral Presentations
Abstract Number: 0014
SHM Converge 2025
Background: Preventive care is a crucial but underutilized component of optimal population health management. Of eligible patients, 69.0% have received pneumococcal vaccine, 24.1% zoster vaccine, and 30.0% hepatitis B vaccine. Cancer screening rates are similarly low, with 12.5% screened for lung cancer and 71.6% for colorectal cancer. Gaps in preventive care are even larger in [...]
Abstract Number: 77
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Disparities in screening mammography use persist among low-income women, even those who are insured, despite the proven mortality benefit. We evaluated the prevalence of breast cancer screening non-adherence among hospitalized women and their receptivity to inpatient screening mammography as a novel approach to increase breast cancer screening rate. Methods: A cross sectional study was [...]
Abstract Number: C9
SHM Converge 2022
Background: To evaluate prevalence of non-adherence to breast cancer screening guidelines after bedside educational intervention and informed individualized risk assessment score during an inpatient stay. Methods: A prospective intervention study was conducted among 507 cancer-free (except skin cancer) women aged 50-75 years hospitalized to a general medicine service. Study intervention included one-on-one bedside education via [...]
Abstract Number: D9
SHM Converge 2022
Background: Despite the proven mortality benefit of screening colonoscopy, approximately 27% of hospitalized women are non-adherent with colorectal cancer screening guidelines. Colonoscopy is the most frequently used test for colorectal cancer screening in US. Although Medicare and most insurance plans would cover screening colonoscopy, colorectal cancer screening has not been part of usual hospital care. [...]
Abstract Number: 230
SHM Converge 2024
Background: Tobacco use is the most widespread preventable cause of cancer and is linked to 30% of cancer-related deaths.(1) Many smokers want to quit but are unsuccessful; tools such as nicotine replacement therapy (NRT) products can increase quit rates by 50-60%.(2) While smoking cessation is the ideal way to combat tobacco-related diseases, screening for diseases [...]
Abstract Number: 532
SHM Converge 2024
Case Presentation: A 27-year-old man without significant medical history presented with constipation and weight loss of 25 pounds in 2 months. A digital rectal examination revealed a fungating mass in the rectum. CT abdomen/pelvis showed the presence of a large intraluminal rectal mass measuring 6.8 X 5.8 X 6.3 cm with no evidence of metastasis. [...]
Abstract Number: D14
SHM Converge 2022
Background: United States Preventive Services Task Force recommends clinicians provide smoking cessation counseling and interventions to all smokers and lung cancer screening with low dose CT scan for high-risk individuals. We aimed to determine the prevalence of smoking cessation counseling and lung cancer screening rate at the residents’ clinic and implement a multimodal plan to [...]
Oral Presentations
Abstract Number: 0014
SHM Converge 2025
Background: Preventive care is a crucial but underutilized component of optimal population health management. Of eligible patients, 69.0% have received pneumococcal vaccine, 24.1% zoster vaccine, and 30.0% hepatitis B vaccine. Cancer screening rates are similarly low, with 12.5% screened for lung cancer and 71.6% for colorectal cancer. Gaps in preventive care are even larger in [...]
Abstract Number: 0608
SHM Converge 2025
Case Presentation: 26-year-old man diagnosed with T-cell acute lymphoblastic leukemia (T-ALL) with CNS involvement in July 2022 completed one cycle of hyperCVAD B and subsequently received maintenance therapy with POMP (prednisone, vincristine, methotrexate, and mercaptopurine) starting in 2023, along with intrathecal chemotherapy. The patient achieved complete remission, with serial MRIs, PET scans, and bone marrow [...]